{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:36:52Z","timestamp":1792759012901,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.semarthrit.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:32:10Z","timestamp":1593527530000},"page":"S2-S10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"special_numbering":"S","title":["The biology of urate"],"prefix":"10.1016","volume":"50","author":[{"given":"Robert T.","family":"Keenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.04.007_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0003","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13075-018-1704-y","article-title":"Monosodium urate crystals reduce osteocyte viability and indirectly promote a shift in osteocyte function towards a proinflammatory and proresorptive state","volume":"20","author":"Chhana","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0004","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204","article-title":"Uric acid and evolution","volume":"49","author":"\u00c1lvarez-Lario","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2004.09.002","article-title":"Uric acid, evolution and primitive cultures","volume":"25","author":"Johnson","year":"2005","journal-title":"Semin Nephrol"},{"issue":"6957","key":"10.1016\/j.semarthrit.2020.04.007_bib0006","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.semarthrit.2020.04.007_bib0007","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1158\/0008-5472.CAN-04-1586","article-title":"Uric acid promotes tumor immune rejection","volume":"65","author":"Hu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0008","doi-asserted-by":"crossref","first-page":"e30456","DOI":"10.1371\/journal.pone.0030456","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.bor.0000209434.82096.1f","article-title":"Recent developments in diet and gout","volume":"18","author":"Lee","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0011","first-page":"132","article-title":"Uric acid elimination in the urine. Pathophysiological implications","volume":"147","author":"Marangella","year":"2005","journal-title":"Contrib Nephrol."},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MNH.0b013e328363ffc8","article-title":"Urate transporters in the genomic era","volume":"22","author":"Sakurai","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108852","article-title":"Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system","volume":"9","author":"Cl\u00e9men\u00e7on","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbamcr.2015.10.002","article-title":"Plasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniques","volume":"1863","author":"Wong","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0015","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/srep03755","article-title":"ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload","volume":"4","author":"Matsuo","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.04.007_bib0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11926-012-0309-8","article-title":"Genetics of hyperuricemia and gout: implications for the present and future","volume":"15","author":"George","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0017","series-title":"The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS program. poster presentation at the 79th scientific session of the American Diabetes Association; June 7\u201311","author":"Li","year":"2019"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0018","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","article-title":"Role of the intestinal tract in the elimination of uric acid","volume":"8","author":"Sorensen","year":"1965","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0020","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/srep02014","article-title":"Common dysfunctional variants in ABCG2 are a major cause of early-onset gout","volume":"31","author":"Matsuo","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez685","article-title":"Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus","author":"Zaidi","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-016-0587-7","article-title":"Urate handling in the human body","volume":"18","author":"Hyndman","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0023","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0024","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout, part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rdc.2014.07.002","article-title":"Gout: a review of nonmodifiable and modifiable risk factors","volume":"40","author":"MacFarlane","year":"2014","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.20761","article-title":"Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey","volume":"52","author":"Choi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0027","series-title":"The principles and practice of medicine","author":"Osler","year":"1901"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0029","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.3390\/nu10080981","article-title":"Sugar-sweetened soft drinks and fructose consumption are associated with hyperuricemia: cross-sectional analysis from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"10","author":"Siqueira","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013191","article-title":"Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies","volume":"6","author":"Jamnik","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0031","first-page":"1","article-title":"Consumption of sugar sweetened beverages and dietary fructose in relation to risk of gout and hyperuricemia: a systematic review and meta-analysis","author":"Ebrahimpour-Koujan","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024171","article-title":"Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohort studies","volume":"9","author":"Ayoub-Charette","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.04.007_bib0033","first-page":"231","article-title":"Update on the Management of Hyperuricemia and Gout","volume":"66","author":"Pillinger","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0034","doi-asserted-by":"crossref","first-page":"k3951","DOI":"10.1136\/bmj.k3951","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"1","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0036","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng.2352","article-title":"Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations","volume":"44","author":"Okada","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0037","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","article-title":"High serum uric acid as a novel risk factor for type 2 diabetes","volume":"31","author":"Dehghan","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10157-011-0532-z","article-title":"Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies","volume":"16","author":"Anzai","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.04.007_bib0039","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0000000000000571","article-title":"Genetic advances in gout: potential applications in clinical practice","volume":"31","author":"Tai","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","article-title":"An update on the genetic architecture of hyperuricemia and gout","volume":"17","author":"Merriman","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0042","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0043","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1038\/ncomms8041","article-title":"Genome wide association analysis identifies three new risk loci for gout arthritis in Han Chinese","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0044","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","article-title":"Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout","volume":"78","author":"Kawamura","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0045","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0046","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0047","first-page":"640","article-title":"Uric acid: friend or foe? Uric acid and cognitive function \"Gout kills more wise men than simple\"","volume":"19","author":"De Giorgi","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0048","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1037\/h0023351","article-title":"The role of glutamic acid in cognitive behaviors","volume":"65","author":"Vogel","year":"1966","journal-title":"Psychol Bull"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0049","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-9877(03)00324-4","article-title":"Uric acid administration for neuroprotection in patients with acute brain ischemia","volume":"62","author":"Chamorro","year":"2004","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(14)70054-7","article-title":"Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised double-blind phase 2b\/3 trial","volume":"13","author":"Chamorro","year":"2014","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.04.007_bib0051","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1161\/STROKEAHA.116.014672","article-title":"Uric acid therapy prevents early ischemic stroke progression \u2013 a tertiary analysis of the URICO-ICTUS Trial (Efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke","volume":"47","author":"Amaro","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0052","first-page":"88","article-title":"Correlations between serum uric acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis","volume":"27","author":"Liu","year":"2012","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0053","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11910-012-0282-7","article-title":"Urate in Parkinson's disease: more than a biomarker?","volume":"12","author":"Chen","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0054","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10072-011-0488-5","article-title":"Serum uric acid levels in multiple sclerosis patients inversely correlate with disability","volume":"32","author":"Guerrero","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson's disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.04.007_bib0056","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer's disease","volume":"21","author":"Kim","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.semarthrit.2020.04.007_bib0057","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000170883","article-title":"Plasma urate and progression of mild cognitive impairment","volume":"6","author":"Irizarry","year":"2009","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0058","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.95.2.675","article-title":"Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis","volume":"95","author":"Hooper","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0059","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ane.12333","article-title":"Associated Inosine to interferon: results of a clinical trial in multiple sclerosis","volume":"131","author":"Mu\u00f1oz Garc\u00eda","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1352458509360547","article-title":"Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial","volume":"16","author":"Gonsette","year":"2010","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.04.007_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/nu10080975","article-title":"Uric acid and cognitive function in older individuals","volume":"10","author":"Tana","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0062","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2016-210767","article-title":"Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study","volume":"77","author":"Latourte","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.04.007_bib0063","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-018-1663-3","article-title":"Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis","volume":"20","author":"Singh","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0064","doi-asserted-by":"crossref","first-page":"63","DOI":"10.11613\/BM.2012.007","article-title":"Uric acid as one of the important factors in multifactorial disorders\u2013facts and controversies","volume":"22","author":"Pasalic","year":"2012","journal-title":"Biochem Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0065","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0066","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4081962","article-title":"What is the biological function of uric acid? an antioxidant for neural protection or a biomarker for cell death","volume":"2019","author":"Liu","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0067","doi-asserted-by":"crossref","first-page":"14351","DOI":"10.1073\/pnas.1001072107","article-title":"Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo","volume":"107","author":"Hershfield","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0068","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11357-016-9871-8","article-title":"Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis","volume":"38","author":"Khan","year":"2016","journal-title":"Age"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0069","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1536\/ihj.18-444","article-title":"Association of uric acid with incident metabolic syndrome in a Japanese general population","volume":"60","author":"Sumiyoshi","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852954","article-title":"Review of hyperuricemia as new marker for metabolic syndrome","author":"Billiet","year":"2014","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0072","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0073","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4239\/wjd.v5.i6.787","article-title":"Linking uric acid metabolism to diabetic complications","volume":"5","author":"Kushiyama","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0074","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1002\/clc.20511","article-title":"Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile","volume":"33","author":"Lippi","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0075","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.1002\/oby.20061","article-title":"Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults","volume":"21","author":"Mangge","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0076","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1093\/milmed\/usy097","article-title":"Hyperuricemia Is associated with a higher prevalence of metabolic syndrome in military individuals","volume":"183","author":"Liu","year":"2018","journal-title":"Mil Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0077","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.numecd.2018.10.001","article-title":"The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals","volume":"29","author":"Liu","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0078","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0079","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0081","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2007.094425","article-title":"Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men","volume":"54","author":"Strasak","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0082","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","article-title":"Association of serum uric acid and cardiovascular disease in healthy adults","volume":"111","author":"Kivity","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0083","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10067-017-3737-z","article-title":"Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients","volume":"36","author":"Hannawi","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"16","key":"10.1016\/j.semarthrit.2020.04.007_bib0084","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009328","article-title":"Association of gout with long-term cardiovascular outcomes among patients with obstructive coronary artery disease","volume":"7","author":"Pagidipati","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mehy.2007.06.018","article-title":"Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?","volume":"70","author":"Duan","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0086","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0087","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0088","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijcard.2015.08.086","article-title":"Uric acid and coronary artery disease: an elusive link deserving further attention","volume":"13","author":"Biscaglia","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0089","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2016.2491","article-title":"Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: a mechanism for uric acid-induced endothelial dysfunction","volume":"37","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","article-title":"Uric Acid \u2013 key ingredient in the recipe for cardiorenal metabolic syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0091","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","article-title":"Uric acid and cardiovascular disease","volume":"484","author":"Ndrepepa","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0092","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0093","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00296-013-2857-2","article-title":"As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout","volume":"34","author":"Tausche","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0094","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/HYPERTENSIONAHA.119.12727","article-title":"Pegloticase treatment significantly decreases blood pressure in patients with chronic gout","volume":"74","author":"Johnson","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0095","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0096","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3346\/jkms.2014.29.8.1077","article-title":"Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men","volume":"29","author":"Kim","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0097","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2169\/internalmedicine.54.4310","article-title":"The effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: a three-year randomized parallel-controlled study","volume":"54","author":"Liu","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0098","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006683","article-title":"effect of febuxostat on ambulatory blood pressure in subjects with hyperuricemia and hypertension: a phase 2 randomized placebo-controlled study","volume":"6","author":"Gunawardhana","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0099","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40261-018-0699-0","article-title":"Multicenter, open-label study of long-term topiroxostat (FYX-051) administration in Japanese hyperuricemic patients with or without gout","volume":"38","author":"Hosoya","year":"2018","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0100","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.112.196980","article-title":"Uric acid reduction rectifies prehypertension in obese adolescents","volume":"60","author":"Soletsky","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.04.007_bib0101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/HYPERTENSIONAHA.116.08488","article-title":"Effect of uric acid lowering agents on endothelial function: a randomized double-blind, placebo-controlled trial","volume":"69","author":"Borgi","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0102","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/ijmm.2015.2148","article-title":"Soluble uric acid increases NALP3 inflammasome and interleukin-1\u03b2 expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway","volume":"35","author":"Xiao","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0103","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3346\/jkms.2013.28.6.855","article-title":"The association between uric acid and chronic kidney disease in Korean men: a 4-year follow-up study","volume":"28","author":"Ryoo","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000324847","article-title":"Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease","volume":"33","author":"Kanbay","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"Weiner","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-142","article-title":"Urate lowering therapy in moderate to severe chronic kidney disease","volume":"22","author":"Levy","year":"2018","journal-title":"Perm J"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.04.007_bib0108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.04.007_bib0109","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.ajkd.2018.07.022","article-title":"Urate-lowering therapy for preventing kidney disease progression: are we there yet?","volume":"72","author":"Tiku","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-018-2051-2","article-title":"Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease","volume":"51","author":"Lee","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0111","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3899\/jrheum.080938","article-title":"Serum urate during acute gout","volume":"36","author":"Schlesinger","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0112","first-page":"1950","article-title":"The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis","volume":"29","author":"Urano","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0113","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","article-title":"Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis","volume":"19","author":"Cronstein","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0115","first-page":"39","article-title":"The role of the NLRP3 inflammasome in gout","volume":"4","author":"Kingsbury","year":"2011","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0116","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820139.2016.1153651","article-title":"Cytokine profile in gout: inflammation driven by IL-6 and IL-18?","volume":"45","author":"Cavalcanti","year":"2016","journal-title":"Immunol Investig"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cyto.2005.11.010","article-title":"Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18","volume":"33","author":"Inokuchi","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0118","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005","article-title":"Molecular pathophysiology of gout","volume":"23","author":"Desai","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0119","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-041015-055539","article-title":"Crystal formation in inflammation","volume":"34","author":"Franklin","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0120","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation","volume":"52","author":"Liu-Bryan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0121","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar3898","article-title":"Enhanced interleukin-1\u03b2 production of PBMCs from patients with gout after stimulation with toll-like receptor-2 ligands and urate crystals","volume":"14","author":"Mylona","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0122","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"proteolytic processing of interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0123","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0124","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bbadis.2013.09.014","article-title":"Tuning NF-\u03baB activity: a touch of COMMD proteins","volume":"1832","author":"Bartuzi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0126","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.berh.2015.04.025","article-title":"Molecular mechanisms of pain in crystal-induced arthritis","volume":"29","author":"Ramonda","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117770","article-title":"Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice\u2013potential role for transient receptor potential ankyrin 1 in gout","volume":"10","author":"Moilanen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12916-017-0922-5","article-title":"What makes gouty inflammation so variable?","volume":"15","author":"Terkeltaub","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0129","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/ar3913","article-title":"Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography","volume":"14","author":"Dalbeth","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597512","article-title":"Monosodium urate in the presence of RANKL promotes osteoclast formation through activation of c-Jun N-terminal kinase","volume":"2015","author":"Choe","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0131","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/annrheumdis-2013-204273","article-title":"Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0132","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12891-015-0762-4","article-title":"Factors influencing the crystallization of monosodium urate: a systematic literature review","volume":"16","author":"Chhana","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0133","doi-asserted-by":"crossref","first-page":"29265","DOI":"10.3390\/ijms161226164","article-title":"Monosodium urate crystal-induced chondrocyte death via autophagic process","volume":"16","author":"Hwang","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0134","doi-asserted-by":"crossref","DOI":"10.1002\/art.39581","article-title":"Silent monosodium urate crystals deposits associate with severe coronary calcification in asymptomatic hyperuricemia: \"An exploratory study","author":"Andr\u00e9s","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0136","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13075-015-0822-z","article-title":"Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study","volume":"17","author":"Larsen","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10495-014-1057-1","article-title":"Oxidative stress by monosodium urate crystals promotes renal cell apoptosis through mitochondrial caspase-dependent pathway in human embryonic kidney 293 cells: mechanism for urate-induced nephropathy","volume":"20","author":"Choe","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0138","doi-asserted-by":"crossref","first-page":"10274","DOI":"10.1038\/ncomms10274","article-title":"Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis","volume":"7","author":"Mulay","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.semarthrit.2020.04.007_bib0139","article-title":"Monosodium urate crystals induced ICAM-1 expression and cell-cell adhesion in renal mesangial cells: implications for the pathogenesis of gouty nephropathy","author":"Luo","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"4611","key":"10.1016\/j.semarthrit.2020.04.007_bib0140","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/art.10614","article-title":"Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages","author":"Landis","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.04.007_bib0141","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.1780390718","article-title":"Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1","volume":"39","author":"Liot\u00e9","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0142","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","article-title":"Cellular characterization of the gouty tophus: a quantitative analysis","volume":"62","author":"Dalbeth","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.04.007_bib0143","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adenocorticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2020.04.007_bib0144","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000046","article-title":"Why does the gout attack stop? A roadmap for immune pathogenesis of gout","volume":"1","author":"Schett","year":"2015","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.04.007_bib0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:02:24Z","timestamp":1758733344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":145,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0049017220301219"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.007","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biology of urate","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}